National Lung Cancer Awareness Month

​

Every November, health systems, advocacy organizations, researchers, and survivors observe National Lung Cancer Awareness Month (LCAM). Lung cancer remains the leading cause of cancer mortality worldwide and within the United States.

​

The primary objectives of the observance are:

​

Promoting Early Detection: Emphasizing the life-saving potential of Low-Dose Computed Tomography (LDCT) scans for individuals at high risk.

Dismantling Stigma: Challenging the myth that lung cancer only affects people who smoke. As advocacy groups frequently note, "Anyone with lungs can get lung cancer."

Advocating for Research Funding: Accelerating clinical trials, genomic testing, targeted therapies, and immunotherapy.

Honoring Patients & Caregivers: Providing community resources, educational outreach, and supportive care for individuals navigating a diagnosis.

​

2. Key Facts & Epidemiological Context

 

Metric / Aspect    Data & Clinical Context  

Prevalence & Impact    Lung cancer accounts for roughly 1 in 5 cancer-related deaths. Approximately 1 in 19 Americans will receive a diagnosis during their lifetime.

Major Types    Non-Small Cell Lung Cancer (NSCLC): ~85% of cases (including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma). Small Cell Lung Cancer (SCLC): ~15% of cases, characterized by faster growth and spread.

Non-Smoker Diagnoses    Between 10% and 20% of people diagnosed with lung cancer have never smoked.

Leading Causes    1. Tobacco smoke (primary and secondhand). 2. Radon gas (the leading cause among non-smokers). 3. Occupational/environmental hazards (asbestos, diesel exhaust, silica, air pollution).

Survival Disparity    Caught early (localized), 5-year relative survival exceeds 60%. However, over 40% of cases are diagnosed at an advanced or distant stage, where 5-year survival drops near 10%.

​

3. Early Detection & Screening Guidelines

The U.S. Preventive Services Task Force (USPSTF) recommends annual screening with Low-Dose CT (LDCT) for individuals meeting all of the following criteria:

Age: 50 to 80 years old.

Smoking History: At least a 20 pack-year history (calculated as packs per day × years smoked; e.g., 1 pack/day for 20 years, or 2 packs/day for 10 years).

Current Status: Currently smoke or have quit within the past 15 years.

Note: Chest X-rays are not an effective tool for screening lung cancer and are not recommended for routine early detection.

​

4. Recognizing Common Warning Signs

Because the lungs have few nerve endings sensitive to pain, symptoms often do not manifest until the disease has progressed. Common signs include:

A new, persistent cough or a cough that worsens over time.

Coughing up blood or rust-colored sputum.

Shortness of breath, wheezing, or unexplained hoarseness.

Persistent chest, shoulder, or back pain that worsens with deep breathing or coughing.

Unexplained weight loss or chronic fatigue.

​

5. Major Themes & Ways to Participate

White Ribbon Campaigns: Wear a pearl or white ribbon to spark dialogue and show solidarity with patients and survivors.

Radon Testing: Test household air levels. Radon test kits are low-cost and readily available through hardware stores and state health departments.

Screening Navigation: Encourage friends and family who meet the high-risk criteria to talk with their primary care provider about an LDCT scan.

Support Groups & Advocacy: Participate in awareness walks, fundraising events, or congressional advocacy to demand equal research funding.

​

6. Authoritative Resources & Additional Reading

American Lung Association (ALA) – State of Lung Cancer: Annual comprehensive reports analyzing state-by-state screening rates, early diagnosis, and survival benchmarks.

Centers for Disease Control and Prevention (CDC) – Lung Cancer Awareness: Evidence-based public health guidance, risk factor education, and eligibility criteria for preventative screening.

GO2 for Lung Cancer: Patient-centered support, free helpline services, clinical trial navigators, and screening risk assessment tools.

LUNGevity Foundation: Dedicated lung cancer research non-profit offering community networks, peer matching, and educational materials.

Lung Cancer Research Foundation (LCRF): Resources detailing biomarker testing, novel targeted therapies, patient webinars, and research grants.

National Cancer Institute (NCI) – Lung and Bronchus Cancer: Authoritative federal information covering pathology, staging, clinical trials, and emerging treatments.